Login / Signup

Post-infectious inflammatory disease in MIS-C features elevated cytotoxicity signatures and autoreactivity that correlates with severity.

Anjali RamaswamyNina N BrodskyTomokazu S SumidaMichela ComiHiromitsu AsashimaKenneth B HoehnNingshan LiYunqing LiuAagam ShahNeal G RavindraJason BishaiAlamzeb KhanWilliam LauBrian SellersNeha BansalPamela GuerrerioAvraham UntermanVictoria HabetAndrew J RiceJason CatanzaroHarsha ChandnaniMerrick LopezNaftali KaminskiCharles S Dela CruzJohn S TsangZuoheng WangXiting YanSteven H KleinsteinDavid van DijkRichard W PierceDavid A HaflerCarrie L Lucas
Published in: medRxiv : the preprint server for health sciences (2021)
Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious complication occurring unpredictably weeks after mild or asymptomatic SARS-CoV2 infection in otherwise healthy children. Here, we define immune abnormalities in MIS-C compared to adult COVID-19 and pediatric/adult healthy controls using single-cell RNA sequencing, antigen receptor repertoire analysis, unbiased serum proteomics, and in vitro assays. Despite no evidence of active infection, we uncover elevated S100A-family alarmins in myeloid cells and marked enrichment of serum proteins that map to myeloid cells and pathways including cytokines, complement/coagulation, and fluid shear stress in MIS-C patients. Moreover, NK and CD8 T cell cytotoxicity genes are elevated, and plasmablasts harboring IgG1 and IgG3 are expanded. Consistently, we detect elevated binding of serum IgG from severe MIS-C patients to activated human cardiac microvascular endothelial cells in culture. Thus, we define immunopathology features of MIS-C with implications for predicting and managing this SARS-CoV2-induced critical illness in children.
Keyphrases